Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |